Q4 FDA Rejects 249 Food Shipments from China
According to data released by the U.S. Food and Drug Administration (FDA), a total of 817 product shipments from China were denied entry into the U.S. between October and December 2024, with 249 of these being food products. This significant number highlights ongoing concerns regarding food safety and regulatory compliance.
Main Reasons for Import Rejections
The primary reasons for the rejection of food products from China during the fourth quarter are as follows:
- Unsafe Additives: 131 shipments
- Appears Unfit for Consumption: 92 shipments
- Labeling Issues: 59 shipments
- Toxic or Harmful Substances: 57 shipments
- All or Part Rotting or Containing Other Inedible Substances: 38 shipments
- Pesticide Residues: 24 shipments
- Unhygienic Processing Conditions: 16 shipments
- Unsafe Coloring Agents: 16 shipments
- Not Registered as a Low-Acid Canned Food Manufacturer: 10 shipments
- Unapproved New Drugs: 6 shipments
- Other Concerns: Various issues, including allergen declaration (1 case), Salmonella (2 cases), Listeria (5 cases), and violations of the FD&C Act (4 cases).
Recommendations for Exporters
To prevent future rejections, it is crucial for exporting companies to:
- Control Quality During Transport: Ensure that food products remain fresh and uncontaminated throughout the shipping process.
- Review Labeling Carefully: Conduct thorough audits of product labels to ensure compliance with U.S. regulations.
- Manage Additive Use: Monitor and control the use of raw materials and additives to avoid non-compliance with safety standards.
By addressing these areas, exporters can improve their chances of successful shipments and maintain their market access to the U.S.
2026-10-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
GM Crop Area Reaches 216 Million Hectares
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
Recommend Reading
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
“No Artificial Colors” Gets Redefined—Why FDA’s Labeling Shift Is Roiling the Food Additive World
-
October Anhydrous Hydrogen Fluoride Market Prices Rise in China
-
Dimethyl Carbonate: Properties and Industrial Applications
-
Hydrobromic Acid: Properties, Uses, and Safety
-
Recent Weak Performance of the Acetic Acid Market in China
-
Recent EVA Market Trend Weakens in China